Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Income from Continuing Operations (2016 - 2025)

OptimizeRx's Income from Continuing Operations history spans 16 years, with the latest figure at 779000.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations rose 108.54% year-over-year to 779000.0; the TTM value through Sep 2025 reached 4830000.0, up 115.2%, while the annual FY2024 figure was 15314000.0, 12.82% up from the prior year.
  • Income from Continuing Operations for Q3 2025 was 779000.0 at OptimizeRx, down from 1532000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 4718000.0 in Q4 2024 and bottomed at 11739540.0 in Q4 2023.
  • The 5-year median for Income from Continuing Operations is 2865000.0 (2023), against an average of 2704836.89.
  • The largest annual shift saw Income from Continuing Operations crashed 8790.01% in 2022 before it skyrocketed 140.19% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 623462.0 in 2021, then crashed by 152.26% to 325836.0 in 2022, then tumbled by 3502.9% to 11739540.0 in 2023, then surged by 140.19% to 4718000.0 in 2024, then crashed by 83.49% to 779000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Income from Continuing Operations are 779000.0 (Q3 2025), 1532000.0 (Q2 2025), and 2199000.0 (Q1 2025).